Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

DOJ Sends Warning In Gender Care Provider Subpoenas No Photo Available

Dan McKay

The announcement of federal subpoenas targeting doctors who offer gender-affirming care signals an escalation in the Trump administrat... (more story)

Courts Face Early Push To Expand Justices' Injunction Ruling No Photo Available

Katie Buehler

In the two weeks since the U.S. Supreme Court curtailed federal judges' ability to issue universal injunctions, Trump administration a... (more story)

Merck's $10B Pulmonary Power Play Is Among Its Top 5 Deals No Photo Available

Al Barbarino

When Merck agreed to purchase respiratory disease-focused Verona Pharma plc for $10 billion, it became one of Merck's largest deals ev... (more story)